• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Atuveciclib Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5752764

Atuveciclib (BAY-1143572) is a potent and highly selective, oral PTEFb/CDK9 inhibitor. It inhibits CDK9/CycT1 (IC50: 13nM). More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Atuveciclib, Inhibitor
Full Product Name
Atuveciclib
Product Synonym Names
BAY-1143572
Form/Format
Solid. Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
387.43
Solubility
DMSO: 128.5mg/mL (331.67mM)
(<1mg/ml refers to the product slightly soluble or insoluble)
Formula
C18H18FN5O2S
SMILES
N=[S@](CC1=CC(NC2=NC(C3=CC=C(F)C=C3OC)=NC=N2)=CC=C1)(C)=O
Target & IC50
CDK9/CycT1: ic50 6nM
CDK3/CycE: ic50 890nM
CDK2/CycE: ic50 1000nM
CDK1/CycB: ic50 1100nM
CDK5/p35: ic50 1600nM
In Vitro
Positive transcription elongation factor b (PTEFb) is a heterodimer of CDK9 and one of four cyclin partners, cyclin T1, cyclin K, cyclin T2a, or cyclin T2b. Atuveciclib demonstrates potent antiproliferative activity against HeLa cells (IC50: 920nM) and MOLM-13 cells (IC50: 310nM).

Product Categories/Family for Atuveciclib, inhibitor

Product References and Citations for Atuveciclib, inhibitor

Lucking U, et al. Identification of Atuveciclib (BAY 1143572), the First Highly Selective, Clinical PTEFb/CDK9 Inhibitor for the treatment,of Cancer. ChemMedChem. 2017 Nov 8;12(21):1776-1793.
Lucking U, et al. Identification of Atuveciclib (BAY 1143572), the First Highly Selective, Clinical PTEFb/CDK9 Inhibitor for the treatment,of Cancer. ChemMedChem. 2017 Nov 8;12(21):1776-1793.

Other Notes

Small volumes of Atuveciclib, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Atuveciclib purchase

MBS5752764 is an inhibitor targeting Atuveciclib.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000